Tag: Novo Nordisk
Novo Nordisk Slips on Q2 Miss and Copycat Drug Pressures
Weak Earnings Follow Downward Guidance Revision Novo Nordisk shares traded lower in premarket action Wednesday after the pharmaceutical company missed Wall Street expectations on both [more…]
New Weight Loss ETF Bets Big on Industry Leaders
The rising popularity of GLP-1 weight loss drugs has captured the attention of investors, leading Roundhill Investments to launch its GLP-1 & Weight Loss ETF [more…]
